$188.00 Original price was: $188.00.$160.00Current price is: $160.00.
Molecular Formula: C₂₂₁H₃₄₂N₄₈O₆₈
Retatrutide 10mg is a synthetic triple receptor agonist peptide composed of 39 amino acids and engineered for enhanced molecular stability in peptide research environments.
Each batch is analytically verified for purity using chromatographic methods and accompanied by batch-specific Certificate of Analysis (COA) documentation.
19 in stock
19 in stock
Retatrutide 10mg is a synthetic peptide analogue designed to interact with multiple incretin-related receptor pathways including glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. The compound is commonly examined in laboratory environments investigating receptor signaling mechanisms, peptide stability, and incretin pathway dynamics.
Peptides are short chains of amino acids that function as signaling molecules within biological systems. Researchers frequently study peptide analogues in controlled laboratory environments to better understand receptor interactions, intracellular signaling pathways, and molecular regulatory processes involved in peptide-mediated communication.
Retatrutide 10mg has become a compound of interest in peptide research due to its multi-receptor interaction profile and structural characteristics designed to enhance stability during experimental investigation.
Peptide Name: Retatrutide 10mg
Quantity: 10mg
Sequence Length: 39 amino acids
Molecular Formula: C₂₂₁H₃₄₂N₄₈O₆₈
Molecular Weight: ~4737.4 g/mol
Purity: ≥99%
Appearance: Lyophilized white powder
Each batch of Retatrutide 10mg undergoes analytical verification to confirm compound identity and purity. Analytical procedures commonly include high-performance liquid chromatography (HPLC) and additional analytical techniques used to evaluate peptide composition and structural integrity.
Verification procedures evaluate:
• peptide purity profile
• chromatographic retention time
• batch consistency
• molecular identity confirmation
Analytical data corresponding to each batch is documented through a Certificate of Analysis (COA).
A Certificate of Analysis provides documentation associated with a specific production lot. These documents typically contain analytical data confirming compound purity and laboratory testing methodology.
COA documentation commonly includes:
• batch identification number
• purity percentage
• chromatographic testing results
• analytical method
• laboratory verification data
Researchers reference COA documentation to maintain traceability and consistency within experimental workflows.
Retatrutide 10mg is produced using solid-phase peptide synthesis (SPPS), a process widely used for assembling complex peptide sequences through sequential amino acid coupling.
The synthesis process typically includes:
sequential amino acid assembly
purification using chromatographic separation
analytical confirmation of molecular identity
lyophilization to maintain compound stability
Following purification, the compound is freeze-dried to preserve structural integrity during storage and transportation.
Lyophilized peptides should be stored under controlled conditions to maintain stability.
Recommended handling considerations include:
• storing in a cool dry environment
• minimizing exposure to moisture and heat
• avoiding repeated freeze-thaw cycles after reconstitution
Proper storage helps maintain compound integrity during laboratory research.
Retatrutide – 5mg
Retatrutide – 10mg
Retatrutide – 15mg
Retatrutide – 30mg
Each vial is labeled with batch identification to support traceability for laboratory research applications.
Researchers investigating incretin signaling pathways often examine related peptide analogues including:
Semaglutide – 10mg
Tirzepatide – 10mg
These peptides are commonly studied in comparative receptor interaction research involving incretin-related signaling systems.
Scientific literature describing incretin signaling pathways and peptide receptor agonists is available through peer-reviewed research databases.
This product is supplied strictly as a laboratory reference material.
Not for human or animal consumption.
Products distributed by Aevitas Research are intended exclusively for laboratory research purposes and must be handled by qualified professionals in controlled research environments.
By purchasing this material, the buyer acknowledges that it will be used in accordance with applicable regulations governing laboratory research products.
Verified compounds. Ready to ship.
© Aevitas Research 2026. All rights reserved
The statements made on this website have not been evaluated by the U.S. Food and Drug Administration, the products offered are not intended to diagnose, treat, cure, or prevent any disease, Aevitas Research is not a compounding pharmacy or chemical compounding facility as defined under Section 503A of the Federal Food, Drug, and Cosmetic Act, and all products are sold strictly for research purposes only and are not for human or animal consumption.